Table 4.

Treatment-related adverse events reported%

	EGB 761 (n = 25)	AChEI (n = 26)	EGb 761+AChEI (n = 26)	p-value Fisher’s exact test
Nausea	2 (8%)	7 (27%)	4 (13.40%)	0.45
Headache	2 (8%)	5 (19.23%)	3 (11.54%)	0.23
Dizziness	1 (4%)	6 (23.07%)	6 (23.07%)	0.55
Constipation	1 (4%)	3 (11.54%)	3 (11.54%)	0.12
Diarrhea	1 (4%)	6 (23.07%)	4 (13.40%)	0.55
Insomnia	3 (12%)	4 (13.40%)	3 (11.54%)	0.10
Somnolence	1 (4%)	3 (11.54%)	2 (7.70%)	0.76
Tremor	0	1 (3.84%)	0	0.31
Aggressiveness	0	1 (3.84%)	0	0.89
Fatigue	1 (4%)	5 (19.23%)	2 (7.70%)	0.73
Abdominal pain	0	2 (7.70%)	0	0.44
Vertigo	0	4 (13.40%)	2 (7.70%)	0.66
Agitation	0	3 (11.54%)	1 (3.84%)	0.46
Skin rashes	0	6 (23.07%)	5 (19.23%)	0.05
Dry mouth	0	2 (7.70%)	2 (7.70%)	0.36